[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI20105991A0 - Adenovirus vectors and methods and uses therefor - Google Patents

Adenovirus vectors and methods and uses therefor

Info

Publication number
FI20105991A0
FI20105991A0 FI20105991A FI20105991A FI20105991A0 FI 20105991 A0 FI20105991 A0 FI 20105991A0 FI 20105991 A FI20105991 A FI 20105991A FI 20105991 A FI20105991 A FI 20105991A FI 20105991 A0 FI20105991 A0 FI 20105991A0
Authority
FI
Finland
Prior art keywords
methods
adenovirus vectors
uses therefor
therefor
adenovirus
Prior art date
Application number
FI20105991A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI20105991A (en
FI124927B (en
Inventor
Joao Dias
Cerullo Vincenzo
Akseli Hemminki
Sari Pesonen
Original Assignee
Oncos Therapeutics Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncos Therapeutics Oy filed Critical Oncos Therapeutics Oy
Publication of FI20105991A0 publication Critical patent/FI20105991A0/en
Priority to FI20105991A priority Critical patent/FI124927B/en
Priority to JP2013529691A priority patent/JP2014500004A/en
Priority to KR1020137010377A priority patent/KR20130108371A/en
Priority to CN2011800533195A priority patent/CN103221544A/en
Priority to AU2011306845A priority patent/AU2011306845C1/en
Priority to PCT/FI2011/050822 priority patent/WO2012038606A1/en
Priority to SG2013019120A priority patent/SG189001A1/en
Priority to BR112013006699A priority patent/BR112013006699A2/en
Priority to US13/825,852 priority patent/US20130243731A1/en
Priority to RU2013118723/10A priority patent/RU2013118723A/en
Priority to EP11770846.1A priority patent/EP2619312A1/en
Priority to CA2812093A priority patent/CA2812093A1/en
Publication of FI20105991A publication Critical patent/FI20105991A/en
Priority to ZA2013/02429A priority patent/ZA201302429B/en
Application granted granted Critical
Publication of FI124927B publication Critical patent/FI124927B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI20105991A 2010-09-24 2010-09-24 Adenovirus vectors and methods and uses thereof FI124927B (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FI20105991A FI124927B (en) 2010-09-24 2010-09-24 Adenovirus vectors and methods and uses thereof
SG2013019120A SG189001A1 (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti - ctla - 4 antibodies
US13/825,852 US20130243731A1 (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti-ctla-4 antibodies
CN2011800533195A CN103221544A (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti-CTLA-4 antibodies
AU2011306845A AU2011306845C1 (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti - CTLA - 4 antibodies
PCT/FI2011/050822 WO2012038606A1 (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti - ctla - 4 antibodies
JP2013529691A JP2014500004A (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vector encoding anti-CTLA-4 monoclonal antibody
BR112013006699A BR112013006699A2 (en) 2010-09-24 2011-09-23 oncolytic adenoviral vector encoding monoclonal anti-ct4-4 antibodies, cell and pharmaceutical composition comprising the same, method of producing ctla-4 specific human monoclonal antibody in a cell and use of said adenoviral vector
KR1020137010377A KR20130108371A (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti-ctla-4 antibodies
RU2013118723/10A RU2013118723A (en) 2010-09-24 2011-09-23 ONCOLITIC Adenovirus VECTORS CODING MONOCLONAL ANTIBODIES AGAINST CTLA-4
EP11770846.1A EP2619312A1 (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti - ctla - 4 antibodies
CA2812093A CA2812093A1 (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti - ctla - 4 antibodies
ZA2013/02429A ZA201302429B (en) 2010-09-24 2013-04-04 Oncolytic adenoviral vectors coding for monoclonal anti-ctla-4 antibodies

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20105991A FI124927B (en) 2010-09-24 2010-09-24 Adenovirus vectors and methods and uses thereof
FI20105991 2010-09-24

Publications (3)

Publication Number Publication Date
FI20105991A0 true FI20105991A0 (en) 2010-09-24
FI20105991A FI20105991A (en) 2012-03-25
FI124927B FI124927B (en) 2015-03-31

Family

ID=42829720

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20105991A FI124927B (en) 2010-09-24 2010-09-24 Adenovirus vectors and methods and uses thereof

Country Status (1)

Country Link
FI (1) FI124927B (en)

Also Published As

Publication number Publication date
FI20105991A (en) 2012-03-25
FI124927B (en) 2015-03-31

Similar Documents

Publication Publication Date Title
FR21C1026I1 (en) SIMIEN ADENOVIRUS AND HYBRID ADENOVIRAL VECTORS
FI20100223A0 (en) Procedure and lift arrangement
BR112012017441A2 (en) compounds and methods
SMT201500291B (en) NEW ANTIMALARIC AGENTS
DK3457689T3 (en) NEW PLANAR PREDICTION MODE
FI20106273A0 (en) Elevator system and procedure
DK3053932T3 (en) Hitherto UNKNOWN CTLA4-IG-IMMUNOADHESINER
FI20105572A0 (en) Modified beta-lactamase and methods and uses related thereto
DK2567097T3 (en) centrifugal
DE112011102851A5 (en) turntable
FI20095751A (en) Non-Ad5 adenoviral vectors as well as methods and uses related thereto
FI20105941A (en) Casting Materials
DK2571902T3 (en) NEW PROCEDURE
BR112012025091A2 (en) Cashier
BR112012025094A2 (en) Cashier
FI20115631A0 (en) IMMUNOSTIMULATORY COMPOUNDS AND USES THEREOF
DE112011104138A5 (en) Mobile inversion drum
IT1401836B1 (en) TESA PORTAOCCHI TESA
FR2958525B1 (en) SPONGE
ES1071902Y (en) THERMOSOLDING AND PRECORT MECHANISM
BR112013013441A2 (en) adhesive-ironing composition and related methods
FR2957892B3 (en) IMPROVED TROTTINETTE
FI20105278A0 (en) New device
FI20105991A0 (en) Adenovirus vectors and methods and uses therefor
FI20105954A0 (en) Mounting frame and procedure

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 124927

Country of ref document: FI

Kind code of ref document: B

MM Patent lapsed